Fitness buffs who can't make it to the gym but still want to exercise can turn to apps for a short, intense workout when they are pressed for time. The U.S. Centers for Disease Control recommend that adults do at least 150 minutes of moderate aerobic activity weekly. But recent studies suggest even short bouts of exercise can have positive health effects.
Tags: Johnson & Johnson
Galapagos loses partner on inflammatory bowel drug
Belgian biotech group Galapagos said on Tuesday that its research partner Janssen Pharmaceutica, a unit of Johnson & Johnson, had pulled out of a program to develop a new drug to treat bowel disease.
Medtronic wins conditional EU approval for $43 billion Covidien buy
U.S. medical device maker Medtronic (MDT.N) gained European Union regulatory approval on Friday for its $43 billion takeover of Covidien Plc (COV.N) after agreeing to sell its Irish rival's drug-coated balloon catheter business.
J&J seeks over $5 billion in damages from Boston Scientific at trial
Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.
Johnson & Johnson to buy private drug developer for $1.75 billion
Johnson & Johnson (JNJ.N) agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.
Latest News
Illinois, US-based software systems provider Wellspring Worldwide bagged $3.5 million in funding from undisclosed investors, according to a document filed with the US Securities and Exchange Commission.
As the New Year starts to roll, private equity firm Carlyle joins the other firms racing to make acquisitions with its $4.15 billion purchase of a Johnson&Johnson unit, the Financial Times reported.
After lackluster activity in the past years, pharmaceutical firms have gotten back to producing new drugs but they encounter challenges in selling them, according to a report on The Wall Street Journal.
California, US-based software developing company Accelrys has acquired Ireland-based software business Qumas in a deal valued at $50 million to expand its products expansion and client base.
Washington-based tech company Microsoft Corp sold a record offering of USD8 billion of bonds in dollars and euros to fund general corporate purposes, according to regulatory filings today.
Top credit ranking Johnson & Johnson reportedly sold USD3.5 billion in a six-part bond issue, its first offering in the last two years. Proceeds from the deal will be used to pay the health care product manufacturer's outstanding debt.
US-based generic drug manufacturer Mylan and two Indian pharmaceutical firms are in talks to buy Chennai-based Bafna Pharmaceuticals for an undisclosed amount, according to two sources familiar with the transaction.
Only three potential buyers from at least five who expressed initial interest were left to bid for the Ortho Clinical Diagnostics business of healthcare firm Johnson & Johnson, according to sources interviewed by Bloomberg.
Sources name the Carlyle Group LP and a combined group from Danaher Corp and Blackstone Group LP to have successfully advanced to the final stage of sale negotiations for J&J's diagnostics unit
